PATL1
Basic information
Region (hg38): 11:59636716-59669037
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PATL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 28 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 5 | 4 |
Variants in PATL1
This is a list of pathogenic ClinVar variants found in the PATL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-59639081-C-T | not specified | Likely benign (Oct 14, 2023) | ||
11-59639159-C-T | not specified | Uncertain significance (Oct 07, 2024) | ||
11-59639160-G-A | not specified | Uncertain significance (Jan 31, 2022) | ||
11-59639304-T-C | not specified | Uncertain significance (Nov 13, 2024) | ||
11-59639325-T-G | not specified | Uncertain significance (Mar 15, 2024) | ||
11-59639340-T-A | not specified | Uncertain significance (Apr 24, 2024) | ||
11-59639350-G-A | not specified | Uncertain significance (Nov 26, 2024) | ||
11-59642896-G-A | not specified | Uncertain significance (Jun 25, 2024) | ||
11-59642978-T-A | not specified | Uncertain significance (Dec 19, 2023) | ||
11-59647769-C-A | not specified | Uncertain significance (Oct 28, 2024) | ||
11-59647797-G-A | not specified | Uncertain significance (Mar 01, 2024) | ||
11-59647810-G-A | not specified | Uncertain significance (Jun 29, 2022) | ||
11-59647821-G-A | not specified | Uncertain significance (Aug 20, 2024) | ||
11-59647838-G-C | not specified | Uncertain significance (Sep 10, 2024) | ||
11-59649516-T-C | not specified | Uncertain significance (Apr 26, 2023) | ||
11-59649535-G-C | not specified | Uncertain significance (Jul 27, 2024) | ||
11-59649556-G-T | not specified | Uncertain significance (Jan 08, 2024) | ||
11-59649566-A-G | Likely benign (Apr 04, 2018) | |||
11-59649606-T-C | not specified | Uncertain significance (Nov 19, 2022) | ||
11-59650764-A-G | not specified | Uncertain significance (Feb 01, 2023) | ||
11-59650782-CTCT-C | Uncertain significance (May 30, 2024) | |||
11-59650791-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
11-59652470-T-C | not specified | Uncertain significance (Jan 30, 2024) | ||
11-59652476-C-A | not specified | Uncertain significance (Sep 30, 2024) | ||
11-59652476-C-T | not specified | Uncertain significance (Sep 26, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PATL1 | protein_coding | protein_coding | ENST00000300146 | 19 | 32265 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.964 | 0.0360 | 124633 | 0 | 9 | 124642 | 0.0000361 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.44 | 278 | 418 | 0.665 | 0.0000226 | 4998 |
Missense in Polyphen | 61 | 133.31 | 0.45758 | 1742 | ||
Synonymous | 0.336 | 138 | 143 | 0.964 | 0.00000680 | 1529 |
Loss of Function | 5.16 | 8 | 45.6 | 0.175 | 0.00000292 | 468 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000339 | 0.0000339 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.0000558 | 0.0000556 |
Finnish | 0.0000466 | 0.0000464 |
European (Non-Finnish) | 0.0000266 | 0.0000265 |
Middle Eastern | 0.0000558 | 0.0000556 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: RNA-binding protein involved in deadenylation-dependent decapping of mRNAs, leading to the degradation of mRNAs. Acts as a scaffold protein that connects deadenylation and decapping machinery. Required for cytoplasmic mRNA processing body (P-body) assembly. In case of infection, required for translation and replication of hepatitis C virus (HCV). {ECO:0000269|PubMed:17936923, ECO:0000269|PubMed:19628699, ECO:0000269|PubMed:20543818, ECO:0000269|PubMed:20584987, ECO:0000269|PubMed:20852261}.;
- Pathway
- RNA degradation - Homo sapiens (human);Metabolism of RNA;mRNA decay by 5, to 3, exoribonuclease;Deadenylation-dependent mRNA decay
(Consensus)
Recessive Scores
- pRec
- 0.0972
Intolerance Scores
- loftool
- rvis_EVS
- 0.07
- rvis_percentile_EVS
- 58.96
Haploinsufficiency Scores
- pHI
- 0.666
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.558
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.333
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Patl1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- deadenylation-dependent decapping of nuclear-transcribed mRNA;cytoplasmic mRNA processing body assembly;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay
- Cellular component
- P-body;cytosol;PML body;nuclear speck;CCR4-NOT complex;cytoplasmic ribonucleoprotein granule
- Molecular function
- RNA binding;protein binding;poly(U) RNA binding;poly(G) binding